Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic, Alzheimer's and Novo Nordisk
Ozempic May Reduce the Risk of Alzheimer’s. That’s Huge for Novo Nordisk.
Ozempic and Wegovy, the two brand names under which the company sells the GLP-1 drug semaglutide, are already blockbusters.
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in diabetes patients.
Novo Nordisk’s Ozempic Linked to Reduced Alzheimer’s Diagnoses
Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s effects in diseases beyond type 2 diabetes and obesity.
2h
Novo Nordisk fights ‘copycat’ versions of Ozempic and Wegovy amid high demand for weight-loss drugs
Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...
2d
on MSN
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
The Danish drugmaker Novo Nordisk contends that semaglutide, the active ingredient in Ozempic and Wegovy, is too complex for ...
1d
Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundup
A new study found a link between NovoNordisk’s blockbuster drug Ozempic and a reduced risk of Alzheimer’s disease. 23andMe, ...
2d
Drugmaker wants an end to Ozempic copies
FDA recalls thousands of antidepressant bottles due to cancer-causing chemical{beacon} Health Care Health Care The Big ...
2d
Novo Nordisk asks US to stop compounding pharmacies from making weight-loss drug copies
Oct 23 (Reuters) - Novo Nordisk (NOVOb.CO) on Tuesday asked the U.S. Food and Drug Administration to ban compounding ...
2d
Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats
Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own ...
FiercePharma
2d
Novo Nordisk asks FDA to prevent compounders from making copycat versions of GLP-1 star semaglutide
“
Novo
Nordisk
’s aim with this nomination is to ensure that patients ... Last month,
Novo
said that it expected its ...
AZ Central
2d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Drugs such as
Novo
Nordisk
's
Ozempic
and Eli Lilly's Mounjaro are approved to treat diabetes patients and have proven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Wegovy
Alzheimer's disease
Food and Drug Administration
semaglutide
Rybelsus
Feedback